• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Merle C. Turner Discusses the Benefits of Utilizing the CORUS CAD Test

Article

Dr. Merle C. Turner, Medical Director of Warner Family Practice in Chandler, Arizona, discusses his perspective on the benefits of the CORUS CAD genomic test in determining whether or not a patient with chronic chest pain needs to be referred to a cardiologist.

Dr. Turner explains that when a patient with symptomatic chronic chest pain has a low score, the pain's origin is not of a cardiac nature, so a referral to a cardiologist is unnecessary. The low score from the CORUS CAD genomic test also tells Dr. Turner to consider alternative causes for the chest pain, such as musculoskeletal, reflux, pneumonia, or gall bladder disease.

Related Videos
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
Jonathan Eisengart
Tiago Biachi, MD, PhD
Irina Dralyuk
Edgardo S. Santos, MD, FACP, FASCO
Irina Dralyuk
Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine
Robin Glasco, Spencer Stuart
Edgardo S. Santos, MD, FACP, FASCO
Tiago Biachi, MD, PhD
Related Content
Karen Winkfield, MD, PhD, Vanderbilt University Medical Center

Building Trust Through Community Engagement in Cancer Care

January 15th 2025
Article

In part 2 of our interview with Karen Winkfield, MD, PhD, she speaks to the importance of ensuring health care accessibility and of knowing that the health care system is not a one-size-fits-all arrangement.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

January 14th 2025
Podcast

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Listen

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy

January 13th 2025
Article

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially benefit from shorter or less-intensive treatment.

Read More

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024
Podcast

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Listen

Travis Osterman, DO, MS, FAMIA, FASCO

AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers

January 9th 2025
Article

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.

Read More

Oscar B. Lahoud, MD, NYU Langone Health

Transparency in Drug Pricing Key to Reducing Patient Burden

January 7th 2025
Article

Cochair of our recent Institute for Value-Based Medicine® event hosted with NYU Langone Health, Oscar B. Lahoud, MD, speaks on his hoped-for top health care priorities under the incoming administration.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.